Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus.
Abstract
BACKGROUND
This study aims to determine whether gestational diabetes mellitus (GDM) is associated with increased arterial stiffness,
inflammatory and pro-atherogenic markers compared to age matched controls.
PATIENTS AND METHODS
This is a cross-sectional study involving 53 pregnant women in the early third trimester of pregnancy consisting of 31 women
with normal pregnancy and 22 women with GDM. Subjects were grouped into GDM and control groups based on modified oral glucose
tolerance test results; they were considered GDM if fasting blood glucose (FBG) was ≥ 6.1 mmol/L and/or the two hours post-glucose
intake was ≥ 7.8 mmol/L. Arterial stiffness was assessed non-invasively using the parameters augmentation index (AIx) obtained
via pulse wave analysis and carotid femoral pulse wave velocity (PWV). Tumor necrosis factor alpha (TNF-alpha), high sensitivity
C- reactive protein (hsCRP) and plasminogen activator inhibitor-1 (PAI-1) were measured using enzyme linked immunoassay technique
(ELISA). Aortic and brachial blood pressure (BP) indices were also recorded.
RESULTS
Mean ages and gestational ages (GA) for the control and GDM groups showed no significant differences (31.1 ± 5.68 vs. 32.9
± 8.46 years; 29.0 ± 2.43 vs. 29.6 ± 1.54 weeks respectively). FBG and 2 hour post-glucose levels were significantly higher
in GDM; (5.27 ± 1.19 vs. 3.94 ± 0.44 mmol/L, p < 0.001; 9.66 ± 1.76 vs. 5.68 ± 1.10 mmol/L, p < 0.001). TNF-alpha, PAI-1 and
hsCRP levels were significantly higher in GDM compared to controls (0.81 ± 0.15 vs. 0.72 ± 0.13 pg/ml, 54.48 ± 13.07 vs. 36.16
± 15.58 cm/ml, 7.91 ± 1.16 vs. 6.70 ± 1.45 mg/l respectively). PWV (8.28 ± 1.48 vs. 7.97 ± 1.12) and AIx (16.73 ± 10.98 vs.
16.13 ± 9.64 %) were not significantly different between the two groups. No significant differences were seen for aortic and
brachial BP, mean arterial pressure and body mass index.
CONCLUSIONS
The inflammatory markers TNF-alpha and hsCRP, and the pro-atherogenic marker PAI-1 were elevated in GDM compared to age matched
controls. No significant difference was seen between the two groups in their arterial stiffness.
Links
Authors
Salmi AA, Zaki NM, Zakaria R, Nor Aliza AG, Rasool AH
Institution
Pharmacology Vascular Laboratory, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia.
Source
VASA. Zeitschrift für Gefässkrankheiten. Journal for vascular diseases 41:2 2012 Mar pg 96-104MeSH
AdultAnalysis of Variance
Biological Markers
Blood Glucose
Blood Pressure
C-Reactive Protein
Carotid Arteries
Case-Control Studies
Compliance
Cross-Sectional Studies
Diabetes, Gestational
Enzyme-Linked Immunosorbent Assay
Female
Femoral Artery
Gestational Age
Glucose Tolerance Test
Humans
Inflammation Mediators
Malaysia
Plasminogen Activator Inhibitor 1
Predictive Value of Tests
Pregnancy
Pregnancy Trimester, Third
Prospective Studies
Pulsatile Flow
Tumor Necrosis Factor-alpha
Up-Regulation
Pub Type(s)
Journal ArticleResearch Support, Non-U.S. Gov't
Language
eng
PubMed ID
22403127
Log In

